The immunogenicity of Haemophilus influenzae: Meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants

Journal of Paediatrics and Child Health

Volumn 33, Issue 2, 1997, Pages 138-141

  Ameratunga, S N ^a,b   Lennon, D R ^a   Entwistle, B ^a   Robinson, E ^a   Ameratunga, R V ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

epidemiology; Haemophilus influenzae; New Zealand; Polynesian; vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PRP OMP; RIBITOL; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG MIXTURE; ERYTHEMA; FEMALE; FEVER; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; LONG TERM CARE; MALE; NEW ZEALAND; NORMAL HUMAN; POLYNESIA; PRIORITY JOURNAL; VACCINATION;

EID: 0030918959     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01016.x     Document Type: Article

References (18)

1. Voss LM, Lennon D, Gillies M. Haemophilus influenzae type b disease in Auckland children 1981-87. NZ Med. J. 1989; 102: 149-51.
2. Lennon D, Voss L, Gillies M, Heffernan H. Epidemiology of invasive Haemophilus influenzae disease in New Zealand (1978-1987). Pediatr. Res. 1989; 25: 183A.
3. Shapiro ED, Ward JI. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol. Rev. 1991; 13: 113-42.
4. Shapiro ED, Capobianco LA, Berg AT, Zitt MQ. The immunogenicity of Haemophilus influenzae type b: Neisseria meningitidis Group B outer membrane protein complex vaccine in infants and young children. J. Infect. Dis. 1989; 160: 1064-7.
5. Santosham M, Wolff M, Reid R, Lukacs L, Ahonkai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr. Infect. Dis. J. 1991; 10: 113-17.
6. Santosham M, Wolff M, Reid R et al. The efficacy and Navajo infants of a conjugate vaccine consisting of a Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N. Engl. J. Med. 1991; 324: 1767-72.
7. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr. Infect. Dis. J. 1993; 12: 484-92.
8. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J. Pediatr. 1992; 120: 184-9.
9. Granoff DM, Anderson EL, Osterholm MT et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 1992; 121: 187-94.
10. Campbell H, Bypass P, Ahonkai VI, Vella PP, Greenwood BM. Serologic responses to an Haemophilus influenzae type b polysaccharide: Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 1990; 86: 102-7.
11. Kayhty H, Peltola H, Kranko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 1983; 147: 1100.
12. Ward JI, Brenneman G, Lepow M, Lum M, Burkhart K, Chiu CY. Haemophilus influenzae type b anticapsular responses to PRP-Pertusis and PRP-D vaccines in Alaska Native infants. J. Infect. Dis. 1988; 158: 719-23.
13. Ward JI, Broome CV, Harrison LH, Shinefield H, Black S. Haemophilus influenzae type b vaccines: Lessons for the future. Pediatrics 1988; 81: 886-93.
14. National Health and Medical Research Council (NH&MRC). Australian Immunisation Procedures Handbook, 5th edn. Commonwealth of Australia, Canberra 1994; 53.
15. Decker MD, Edwards KM, Bradley R, Palmer P. Responses of children to booster immunization with their primary conjugate. Haemophilus influenzae type b vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. J. Pediatr. 1993; 122: 410-13.
16. Ameratunga SN, Lennon DR, Martin D. Invasive Haemophilus Disease: Prospects for prevention in New Zealand. NZ Med. J. 1994; 107: 193-4.
17. Mohle-Boetani JC, Ajello G, Brenneman G et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Hib vaccines. Pediatr. Infect. Dis. J. 1993; 12: 589-93.
18. Baker M, Martin D. Hib disease rate plummets following immunisation programme. NZ Public Health Report 1995; 2(2): 13-14.